Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Is Merck the Perfect Stock?
Motley Fool
Wednesday, November 24, 2010 - 8:34am
tags:
Merck
Twin blows spur a crisis of confidence in RNAi
Fierce Biotech
Wednesday, November 24, 2010 - 8:29am
tags:
RNAi, Roche, Alnylam
Patience With Bristol-Myers Squibb
Traders Huddle
Wednesday, November 24, 2010 - 8:18am
tags:
Bristol-Myers Squibb
'Record' drug shortages include cancer meds
Fierce Pharma
Wednesday, November 24, 2010 - 8:14am
tags:
drug shortages
Ligand Pharma says Roche terminates agreement
Reuters
Wednesday, November 24, 2010 - 8:13am
tags:
Roche, Ligand, hepatitis C
Abbott India Advances, Solvay Pharma Tumbles on Merger Plan
Bloomberg
Wednesday, November 24, 2010 - 7:59am
tags:
Abbott Laboratories, India, Solvay, M&A
Lilly, Acrux get FDA OK for topical testosterone
Marketwatch
Wednesday, November 24, 2010 - 7:58am
tags:
Acrux, Eli Lilly, FDA, testosterone, Axiron
Vt. law on drug data mining ruled unconstitutional
Yahoo/AP
Tuesday, November 23, 2010 - 10:06pm
tags:
data mining, Vermont
Positive Data on Alexion's Soliris
Yahoo/Zacks.com
Tuesday, November 23, 2010 - 10:05pm
tags:
Soliris, Alexion, aHUS, atypical hemolytic uremic syndrome
[video] Sell Pfizer!: Against the Grain
TheStreet.com
Tuesday, November 23, 2010 - 10:03pm
tags:
Pfizer
Novartis CEO Denies Layoff Rumors, Staff Still Worried
BNET Pharma
Tuesday, November 23, 2010 - 2:19pm
tags:
Novartis, cafepharma, layoffs, Joe Jimenez
Talecris Enters Oversold Territory
Yahoo/Zacks.com
Tuesday, November 23, 2010 - 2:15pm
tags:
Talecris
Novartis Must Pay $12M Over Jaw-Bone Damage
Pharmalot
Tuesday, November 23, 2010 - 2:14pm
tags:
settlements, Novartis, Aredia, Zometa, osteoporosis
Dr Reddy to buy Glaxo's US penicillin site
Yahoo/AP
Tuesday, November 23, 2010 - 2:12pm
tags:
GSK, Dr Reddy's, penicillin
Medicis Pharmaceutical: The Trend Continues Lower
Benzinga
Tuesday, November 23, 2010 - 10:52am
tags:
Medicis
Amgen Holder Invesco Says Potential Actelion Deal Not `Hugely Compelling'
Bloomberg
Tuesday, November 23, 2010 - 10:49am
tags:
Amgen, M&A, Actelion
Cumberland Pharma Is Flying Under the Radar
Seeking Alpha
Tuesday, November 23, 2010 - 10:48am
tags:
Cumberland, Acetadote
Study: Gilead's ($GILD) Truvada cuts HIV risk 44%
Fierce Pharma
Tuesday, November 23, 2010 - 10:40am
tags:
Gilead Sciences, Truvada, HIV
Analyst Recap: Swiss Drugmaker Novartis Has Strong Pipeline
Seeking Alpha
Tuesday, November 23, 2010 - 10:38am
tags:
Novartis, pipelines, emerging markets, R&D
Aoxing Moves Closer to Commercial Production of Narcotic Drug
Seeking Alpha
Tuesday, November 23, 2010 - 10:37am
tags:
Aoxing, narcotics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.